NZVC — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Marama Labs develops optical spectroscopy instruments for life-sciences research, leveraging surface-enhanced Raman spectroscopy and nanoparticle characterization technology.
BiotechDeep TechHardwareHealthtechDublin, IE
Eric Le Ru(Founder)inBrendan Darby(Co-founder & CEO)inMatthias Meyer(Co-founder)in
Co-investorsBooster Innovation FundNZ Growth Capital PartnersQuidnet VenturesRadar VenturesWNT VenturesIcehouse Ventures+2 more
Siren Biotechnology develops next-generation AAV (adeno-associated virus) platforms for gene therapy applications, including gene repair, gene transfer, and gene editing.
BiotechDigital HealthMedical DevicesSan Francisco, US
Dr. Nicole Paulk(CEO, Founder, and President)inLauren Kelly(Founder)inSharon Tetlow(Director)Brad Allen(Director)
Co-investorsArtis VenturesAvilaCarnrite VenturesCivilization Ventures Management, LlcGaingelsHAWKTAIL+4 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
HealthNow
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







__Twitter.png)